Vaxart Balance Sheet Health
Financial Health criteria checks 6/6
Vaxart has a total shareholder equity of $57.8M and total debt of $6.4M, which brings its debt-to-equity ratio to 11.1%. Its total assets and total liabilities are $91.8M and $34.0M respectively.
Key information
11.1%
Debt to equity ratio
US$6.43m
Debt
Interest coverage ratio | n/a |
Cash | US$39.71m |
Equity | US$57.81m |
Total liabilities | US$34.03m |
Total assets | US$91.83m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: VXRT *'s short term assets ($45.5M) exceed its short term liabilities ($13.7M).
Long Term Liabilities: VXRT *'s short term assets ($45.5M) exceed its long term liabilities ($20.3M).
Debt to Equity History and Analysis
Debt Level: VXRT * has more cash than its total debt.
Reducing Debt: VXRT *'s debt to equity ratio has reduced from 190% to 11.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VXRT * has sufficient cash runway for 7 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: VXRT * is forecast to have sufficient cash runway for 8 months based on free cash flow estimates, but has since raised additional capital.